CYP19A1 and breast cancer: Due to an abundance of this aromatase-expressing tissue, obese postmenopausal women typically have higher levels of circulating estradiol [13-15], and researchers have posited that this may contribute to the observed increase in breast cancer risk and worse outcome in this population.